197 related articles for article (PubMed ID: 15665283)
1. Tumor susceptibility of Rassf1a knockout mice.
Tommasi S; Dammann R; Zhang Z; Wang Y; Liu L; Tsark WM; Wilczynski SP; Li J; You M; Pfeifer GP
Cancer Res; 2005 Jan; 65(1):92-8. PubMed ID: 15665283
[TBL] [Abstract][Full Text] [Related]
2. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
3. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas.
Dammann R; Takahashi T; Pfeifer GP
Oncogene; 2001 Jun; 20(27):3563-7. PubMed ID: 11429703
[TBL] [Abstract][Full Text] [Related]
4. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1.
Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP
Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene.
Li J; Wang F; Protopopov A; Malyukova A; Kashuba V; Minna JD; Lerman MI; Klein G; Zabarovsky E
Oncogene; 2004 Aug; 23(35):5941-9. PubMed ID: 15208682
[TBL] [Abstract][Full Text] [Related]
8. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
9. Targeted disruption of the 3p12 gene, Dutt1/Robo1, predisposes mice to lung adenocarcinomas and lymphomas with methylation of the gene promoter.
Xian J; Aitchison A; Bobrow L; Corbett G; Pannell R; Rabbitts T; Rabbitts P
Cancer Res; 2004 Sep; 64(18):6432-7. PubMed ID: 15374951
[TBL] [Abstract][Full Text] [Related]
10. [Methylation of the promoter region of the RASSF1A gene, a candidate tumor suppressor, in primary epithelial tumors].
Loginov VI; Maliukova AV; Seregin IuA; Khodyrev DS; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Kiselev LL; Zabarovskiĭ ER; Braga EA
Mol Biol (Mosk); 2004; 38(4):654-67. PubMed ID: 15456137
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of RASSF1a in uveal melanoma.
Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
[TBL] [Abstract][Full Text] [Related]
12. Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy.
Tommasi S; Besaratinia A; Wilczynski SP; Pfeifer GP
Oncogene; 2011 Feb; 30(6):690-700. PubMed ID: 20890300
[TBL] [Abstract][Full Text] [Related]
13. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
14. RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of beta-catenin by interacting with betaTrCP.
Estrabaud E; Lassot I; Blot G; Le Rouzic E; Tanchou V; Quemeneur E; Daviet L; Margottin-Goguet F; Benarous R
Cancer Res; 2007 Feb; 67(3):1054-61. PubMed ID: 17283138
[TBL] [Abstract][Full Text] [Related]
15. [Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors].
Maliukova AV; Loginov VI; Khodyrev DS; Kadyrova EL; Pronina IV; Ivanova TA; Kiselev FL; Zabarovskiĭ NP; Braga EA
Mol Biol (Mosk); 2004; 38(6):1005-13. PubMed ID: 15612586
[TBL] [Abstract][Full Text] [Related]
16. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
[TBL] [Abstract][Full Text] [Related]
17. Identification of epigenetic aberrant promoter methylation of RASSF1A in serum DNA and its clinicopathological significance in lung cancer.
Wang Y; Yu Z; Wang T; Zhang J; Hong L; Chen L
Lung Cancer; 2007 May; 56(2):289-94. PubMed ID: 17267069
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the RASSF1A gene in human cancers.
Pfeifer GP; Yoon JH; Liu L; Tommasi S; Wilczynski SP; Dammann R
Biol Chem; 2002 Jun; 383(6):907-14. PubMed ID: 12222680
[TBL] [Abstract][Full Text] [Related]
19. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of suppressive role of RASSF1A gene at 3p21.3 in lung cancer cell line A549].
Zhang S; Shao K; Zhang CY; Zhou F; Wang W; Xiong MH; He J
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):908-11. PubMed ID: 16029530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
